Literature DB >> 15039913

Evaluation of apoptosis, proliferation intensity and metallothionein (MT) expression in comparison with selected clinicopathological variables in primary adenocarcinomas of the large intestine.

Małgorzata Dumańska1, Piotr Dziegiel, Mirosław Sopel, Andrzej Wojnar, Maciej Zabel.   

Abstract

Tumour growth and expansion are the result of proliferative activity and the capacity to eliminate cells by apoptosis and/or necrosis. The present study was aimed at comparing the apoptosis and proliferation intensity in cells of adenocarcinomas of the large intestine with the expression of metallothionein (MT), the grade of the tumour and the depth to which the tumour infiltrated the intestinal wall. The TUNEL technique and immunocytochemical reactions (expression of caspase-3, Ki-67, MT) were used to detect apoptosis. The results demonstrated augmented levels of all the variables examined, positively correlated with grade of malignancy, G, and with the depth of intestinal wall infiltration by the tumour cells. The testing of apoptosis, proliferation and MT expression may prove useful in the appraisal of the growth and progression of primary adenocarcinomas in the large intestine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039913

Source DB:  PubMed          Journal:  Folia Morphol (Warsz)        ISSN: 0015-5659            Impact factor:   1.183


  2 in total

1.  Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.

Authors:  Jaromir Gumulec; Martina Raudenska; Vojtech Adam; Rene Kizek; Michal Masarik
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

2.  Genetic polymorphisms (rs10636 and rs28366003) in metallothionein 2A increase breast cancer risk in Chinese Han population.

Authors:  Di Liu; Meng Wang; Tian Tian; Xi-Jing Wang; Hua-Feng Kang; Tian-Bo Jin; Shu-Qun Zhang; Hai-Tao Guan; Peng-Tao Yang; Kang Liu; Xing-Han Liu; Peng Xu; Yi Zheng; Zhi-Jun Dai
Journal:  Aging (Albany NY)       Date:  2017-02-22       Impact factor: 5.682

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.